Content Type: Article

  • FDA Issues Final Guidance on Informed Consent in Clinical Investigations

    FDA Issues Final Guidance on Informed Consent in Clinical Investigations

    ARTICLE / CLIENT ALERT

    FDA Issues Final Guidance on Informed Consent in Clinical Investigations

    September 6, 2023

    Read time: 10 min

    Key takeaways
    Overview

    On August 15, 2023, the US Food and Drug Administration (FDA) finalized Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors (final guidance). This document finalizes, with new examples and limited updates and modifications, the FDA’s draft guidance entitled Informed Consent Information Sheet: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors, issued on July 15, 2014.

    In depth

    The final guidance supersedes the FDA’s guidance entitled A Guide to Informed Consent, issued in September 1998, and finalizes the 2014 draft guidance. The final guidance reflects the FDA’s current thinking and recommendations regarding informed consent and describes FDA regulatory requirements to help protect human subjects’ rights and welfare in clinical investigations.

    In the nearly 10 years since the draft guidance was issued, the processes by which clinical trials and other human subjects research are conducted have evolved with technological advancements (e.g., platforms that can support decentralized research) and enhanced scientific knowledge (e.g., the ability to target therapies more closely to genetic variations). Based on clinical research experience during the last decade, including research conducted during the COVID-19 pandemic, the final guidance offers important clarifications and examples for institutional review boards (IRBs), investigators and sponsors as federal agencies continue efforts to harmonize regulations applicable to conducting human subjects research (detailed below).

    However, further updates and clarifications are likely forthcoming as the FDA continues its notice-and-comment rulemaking process regarding informed consent requirements. That process could result in future changes—to the extent practicable and consistent with other statutory provisions—to align FDA informed consent requirements with revisions to the Federal Policy for the Protection of Human Subjects adopted by the US Department of Health and Human Services and several other federal departments and agencies. (That policy is known as the 2018 Common Rule, which we discussed in previous commentary.) The FDA cautions that it may amend the final guidance to reflect any such changes or to address new questions related to informed consent.

    SUMMARY OF CONSENT PROCESS AND REGULATORY REQUIREMENTS FOR INFORMED CONSENT

    The FDA opens the final guidance by explaining that informed consent involves more than just obtaining a subject’s signature on a consent form. It is a multi-step process that provides a potential research subject with sufficient information about a clinical investigation, facilitates the potential subject’s understanding of that information, and provides an adequate opportunity for the potential subject to ask questions and to carefully consider whether to participate. After the potential subject has voluntarily agreed and signed a consent form, the informed consent process also requires continued disclosure of new or additional information as the clinical investigation progresses, or as the enrolled subject or situation requires.

    The FDA provides guidance regarding the requirements for informed consent set forth in FDA regulations at 21 CFR §§ 50.20 et seq., including a detailed discussion of the eight basic elements that must be provided to the potential subject and examples of situations in which additional elements should be included. The examples include situations involving vulnerable populations and situations that require disclosure of information about unforeseeable risks or consequences of withdrawal from the research. The guidance reiterates that where possible, individuals should be informed about the number of subjects participating in the trial. It also notes that the consent materials must include a statement about the availability of information about the investigation on ClinicalTrials.gov (to the extent sponsors and investigators determine that the investigation meets the definition of an “applicable clinical trial” set forth at 42 CFR § 11.10(a)).

    The FDA concludes this section with guidance on documenting informed consent and situations where alternative methods of obtaining informed consent would be appropriate. The FDA clarifies that obtaining consent through electronic means may be an appropriate alternative to paper consent forms (citing to the FDA’s Guidance for Institutional Review Boards, Investigators, and Sponsors, Use of Electronic Informed Consent in Clinical Investigations). The FDA also notes that if the signed document cannot be retrieved (e.g., because the subject is in isolation due to an infectious disease) and electronic consent is not available, it is acceptable to instead include in the study records a photograph of the signed consent form along with an appropriate attestation. The attestation should be made by the person entering the photograph into the record, should state how the photograph was obtained, and should verify that the photograph depicts the informed consent form signed by the subject.

    IRB RESPONSIBILITIES

    The FDA offers guidance on specific areas that IRBs should consider when reviewing and approving consent forms for compliance with FDA regulatory requirements, and to ensure that the informed consent process adequately protects the rights and welfare of subjects participating in the clinical investigation:

    • IRBs are responsible for reviewing all materials used in the informed consent process, not just the informed consent form itself. This means that the IRB should also review and approve recruitment materials and any other informational materials that will be provided to potential subjects for compliance with FDA requirements.
    • IRBs should review the adequacy and appropriateness of wording used in the informed consent form as well as its overall length and presentation to ensure that it is not too complex, legalistic or overwhelming to potential subjects.
    • IRBs must confirm that investigators will seek consent in ways that minimize the possibility of coercion and undue influence. They should confirm that consent will be appropriately documented and that any alternative methods for obtaining consent will accomplish the goals of the informed consent process. The FDA clarifies that certain administrative changes, such as correction of typographical or spelling errors or changes to telephone numbers, may be submitted at any time and do not require formal review and approval.
    • IRBs should establish procedures for the timely, efficient and effective review of new information about the research or changes in the clinical investigation. Investigators or sponsors should notify the IRB of new findings relevant to a subject’s decision to continue participation, approve revisions to the protocol or consent materials before they are initiated, implement an expedited review process for minor changes, and develop criteria for identifying revised consent forms to reduce the likelihood of continued use of a previously approved version. The FDA also provides new examples of scenarios in which additional information does not need to be provided, such as when the subject has completed active participation in the study or when the new information is unlikely to affect the subject’s decision to continue participating in the study.

    CLINICAL INVESTIGATOR RESPONSIBILITIES

    The FDA next offers guidance for investigators regarding their role and responsibilities in the informed consent process:

    • Investigators should notify the IRB of the consent process and provide copies of all patient- or subject-facing information regarding the investigation. Investigators should receive approval from the IRB prior to recruiting and enrolling subjects in the trial and should update the IRB and make necessary revisions to the process and information as the investigation progresses.
    • Investigators should only delegate the responsibility for obtaining informed consent to individuals who are qualified by education, training and experience; are knowledgeable about the specific clinical investigation; and have appropriate training and credentials to answer questions or address subjects’ concerns.
    • Investigators should consider whether to provide subjects with information related to financial relationships or interests that might have an effect on the investigation or interactions with subjects. Investigators should also consider other measures, such as involving another individual in the consent process who does not have a potential or actual conflict of interest or implementing independent monitoring of the consent process. Although the FDA directs these conflict-of-interest considerations to investigators, the FDA clarifies that the IRB has final responsibility for determining whether subjects should be provided with information regarding financial interests as part of the informed consent process.

    SPONSOR RESPONSIBILITIES

    The FDA provides guidance on sponsors’ role in the informed consent process. For example, the FDA clarifies the following issues:

    • If the sponsor provides investigators with a model consent form for adaption and use in the investigation, the sponsor should promptly provide the investigator with any revisions or modifications to the model form and work with the investigator to ensure that the IRB reviews and approves such modifications or revisions.
    • For multicenter clinical investigations reviewed by more than one IRB, the sponsor should share substantive modifications made by one local IRB with all other investigators and their IRBs. The sponsor should consider sharing this information using a modified model consent form. For multicenter investigations with a central IRB cooperating with local IRBs, the sponsor should forward substantive modifications to the central IRB.
    • Sponsors of medical device studies that will have personnel present during investigational procedures or follow-up visits or will otherwise engage in activities that will directly affect the subject, should describe those activities in the informed consent form.

    FDA REVIEW CONSIDERATIONS

    The guidance includes insights into the required submission of informed consent materials to the FDA in connection with a clinical investigation:

    • FDA regulations do not specifically require submission of consent materials in connection with an investigational new drug application (IND). However, the FDA generally requires consent forms associated with treatment INDs and protocols, as well as INDs conducted under exceptions from informed consent requirements in connection with emergency research, to be submitted for review.
    • The FDA considers several factors when determining whether to require the submission of materials in connection with other clinical investigations of drugs. These factors include unusual toxicity in nonclinical studies, vulnerable study populations, unusual study design, potential for serious risk to human subjects, and investigations that require subjects to forgo or delay effective treatment.
    • All forms and informational materials that will be provided to subjects in connection with clinical investigations of medical devices that require an investigational device exemption application must be submitted to the FDA for review.

    The FDA reiterates that its review of informed consent forms is not a substitute for IRB review and approval.

    FREQUENTLY ASKED QUESTIONS

    The guidance closes with a series of new frequently asked questions (FAQs) related to the protection of human subjects. The FAQs address a variety of topics:

    • Enrollment of children, non-English speakers, individuals with low literacy and individuals with disabilities in clinical investigations
    • Individuals eligible to serve as a subject’s legally authorized representative
    • Electronic means of obtaining consent
    • Subject participation in multiple trials simultaneously (reiterating the FDA’s general discouragement as stated in the draft guidance, but acknowledging that co-enrollment may be appropriate in certain circumstances, such as rare disease studies that evaluate different aspects of a condition)
    • Subject withdrawal from studies or suspended or terminated studies
    • Whether informed consent is required to review patient records.

    The final guidance does not address some of the novel issues associated with informed consent in a digital age, such as the following:

    • How best to engage in the informed consent process remotely (although the FDA issued draft guidance on this topic in May 2023)
    • How privacy and security discussions related to data capture tools (such as smartphones) used during the clinical trial, but not studied as part of the clinical trial, should be incorporated into informed consent materials
    • How AI tools might facilitate the informed consent process (such as by answering subject questions).

    The final guidance also declines to address the interplay of FDA informed consent requirements and HIPAA authorization requirements.

    Authors

    Jennifer S. Geetter

    Partner

    Washington, DC

    Sam Siegfried

    Partner

    Chicago

    More insights

  • SEC Expands FINRA Oversight of Proprietary Trading Firms

    SEC Expands FINRA Oversight of Proprietary Trading Firms

    ARTICLE / CLIENT ALERT / US POLICY

    SEC Expands FINRA Oversight of Proprietary Trading Firms

    September 6, 2023

    Read time: 5 min

    Key takeaways
    Overview

    On Aug. 23, 2023, the US Securities and Exchange Commission (“Commission”) adopted amendments[1] (“Amendments”) to the Securities Exchange Act of 1934 (“Exchange Act”) to require certain SEC-registered dealers that were previously exempt from national securities association[2] membership to register with the Financial Industry Regulatory Authority (“FINRA”).

    Background and Current Regulatory Framework

    Section 15(b)(8) of the Exchange Act requires SEC-registered broker-dealers to become FINRA members, unless the broker-dealer effects transactions in securities solely on an exchange of which it is a member.[3] Currently, Exchange Act Rule 15b9-1 exempts any dealer that transacts on exchanges of which it is not a member or in the off-exchange market from the FINRA membership requirement if such dealer:

    1. Is a member of a national securities exchange,
    2. Carries no customer accounts, and
    3. Primarily earns off-member exchange income from transactions for the dealer’s own account with or through another registered broker-dealer or through an Intermarket Trading System.[4]

    While broker-dealers relying on current Exchange Act Rule 15b9-1 are required to limit the annual gross income they derive from securities transactions otherwise than on a national securities exchange of which they are a member to an amount no greater than $1,000, income derived from transactions for the dealer’s own account with or through another registered broker or dealer do not count towards this limitation.[5]

    Due to the above exclusion of transactions for a dealer’s own account from the de minimis exception, Exchange Act Rule 15c9-1 is currently utilized by dozens of proprietary trading firms to reduce operational costs.

    Amendments to Exchange Act Rule 15b9-1

    Once effective, Exchange Act Rule 15b9-1 will only apply where a broker or dealer is a member of a national securities exchange, carries no customer accounts, and effects transactions solely on the national securities exchanges of which it is a member, unless one of two narrow exceptions applies.

    The first exemption applies to off-member-exchange securities transactions that result solely from orders that are routed by a national securities exchange of which such dealer is a member to comply with order protection regulatory requirements.[6]

    The second exemption applies to off-member-exchange securities transactions that are solely for the purpose of executing the stock leg of a stock-option order. Broker-dealers relying on the second exemption will, under the amended rule, be required to establish written policies and procedures “reasonably designed to ensure and demonstrate that such transactions are solely for the purpose of executing the stock leg of a stock-option order.”[7] The Adopting Release notes that the SEC anticipates self-regulatory organizations will look to these procedures and related documentation in assessing firms’ compliance with this exemption.[8]

    The Amendments will become effective 60 days after the date of publication in the Federal Register and the compliance date (that is, the time by which impacted firms will need to become registered with FINRA) will be one-year after the date of publication in the Federal Register.

    Conclusion

    By eliminating the general exclusion of transactions for a dealer’s own account from Amended Exchange Act Rule 15b9-1, dozens of proprietary trading firms that regularly effect transactions through single-dealer platforms, in third-party alternative trading systems or just in over-the-counter dealer transactions that are currently not registered with FINRA, will either need to curtail their proprietary trading activities or become a FINRA member.

    As a result of the adoption of the Amendments, FINRA is expected to quickly implement previously proposed amendments to its Transaction Activity Fee (“TAF”) to exclude from the calculation of a firm’s TAF assessment transactions by FINRA-member propriety trading firms that are executed on exchanges of which they are members.[9] FINRA-member firms that currently operate on-exchange proprietary trading strategies should evaluate separating those strategies into a newly-formed FINRA-member that exclusively engages in propriety trading activities to take advantage of FINRA’s proposed TAF fee exclusions.

    Additionally, Private Funds that are currently assessing the potential impact of the SEC’s proposal to redefine the definition of ‘Dealer’ to cover certain private funds and advisors (see Alert here) should incorporate the elimination of most of the benefits of the Exchange Act Rule 15b9-1 exclusion from FINRA membership into their transition planning.

    Authored by Julian Rainero, William J. Barbera, Derek N. Lacarrubba, and Kristopher J. Kendall.

    If you have any questions concerning this Alert, please contact your attorney or one of the authors.

    In depth
    Authors

    William J. Barbera

    Partner

    New York – 919 Third Avenue

    More insights

  • SEC Cracks Down on NFTs With First-Of-Its-Kind Enforcement Action

    SEC Cracks Down on NFTs With First-Of-Its-Kind Enforcement Action

    ARTICLE / CLIENT ALERT

    SEC Cracks Down on NFTs With First-Of-Its-Kind Enforcement Action

    September 5, 2023

    Read time: 7 min

    Key takeaways
    Overview

    On August 28, 2023, the US Securities and Exchange Commission (SEC) announced an enforcement action against Impact Theory, LLC, alleging that Impact Theory’s public sale of approximately $30 million in crypto assets violated Section 5 of the Securities Act of 1933. The SEC alleged that the crypto assets, which Impact Theory branded as “Founder’s Keys,” met the definition of a “security” under the Howey test even though they were sold as non-fungible tokens (NFTs). Without admitting or denying the findings, Impact Theory and the SEC entered into a consent decree settling the allegations for an aggregate payment of approximately $6 million in disgorgement, interest and civil money penalties.

    Although SEC enforcement actions in the crypto industry have become more common, this action marks the first one against an issuer of NFTs and may foreshadow the SEC’s interest in regulating the market for issuances and sales of NFTs that it determines are “crypto asset securities.” Notably, two commissioners dissented from the SEC action and attempted to guide the SEC to address critical issues surrounding NFTs.

    In depth

    SEC ALLEGATIONS OF CRYPTO ASSET SECURITIES

    Impact Theory markets itself as a media and entertainment company with the mission of introducing the world to empowering ideas at scale through story. Impact Theory issued and sold NFTs (aka Founder’s Keys) described to grant holders as access to ad-free content, an online school designed to teach users the skills needed to reach their potential, digital collectibles, opportunities with its Web3 partners, discounts on outside products and a story-based avatar creation tool and experience. The Founder’s Keys were offered at three tiers, with each tier providing varying degrees of benefits. Impact Theory offered Founder’s Keys NFTs through its Founder’s Keys website and facilitated sales through secondary markets, such as crypto asset trading platforms. Impact Theory received a 10% “royalty” on each secondary market sale.

    In bringing this enforcement action, the SEC applied the definition of “investment contract” as articulated by the Supreme Court of the United States in Securities & Exchange Commission v. W.J. Howey Co.¸ 328 U.S. 293 (1946) (Howey test). Under the Howey test, investment contracts involve an investment of money in a common enterprise with a reasonable expectation of profits derived from the efforts of others. Here, the SEC argued that purchasers of Founder’s Keys had a reasonable expectation of obtaining future profits. In its allegations that the Founder’s Keys were offered and sold as “investment contracts,” the SEC highlighted the promises of a return on investment that appeared in Impact Theory’s marketing and promotional materials. The SEC quoted Impact Theory’s public statements that the Founder’s Keys would deliver “tremendous value.” For example, Impact Theory’s founders stated, “If you’re paying 1.5 [ETH], you’re going to get some massive amount more than that. So no one is going to walk away saying, ‘Oh man, I don’t think I got value here.’ I’m freakishly bullish on that. I will do whatever it takes to make sure that that is true.” Impact Theory also stated that it would use the proceeds from sales for “development,” “bringing on more team [members]” and “creating more projects,” which the SEC alleged had developed an expectation that profits would be based on Impact Theory’s managerial and entrepreneurial efforts. For example, Impact Theory’s founders stated, “I will make sure that we do something that by any reasonable standard, people got a crushing, hilarious amount of value.” The SEC also quoted Impact Theory’s public statements that the fortunes of purchasers, Impact Theory and Impact Theory’s founders were all linked together. For example, Impact Theory’s founders stated, “Our goal is to make sure that as Impact Theory is enriched, as [its founders] are enriched, as our team here at Impact Theory is enriched, that you guys also are enriched. And so that is why we are so aggressively behind NFTs.” The SEC did not allege that Impact Theory’s conduct was fraudulent.

    In connection with the settlement, the SEC considered remedial acts undertaken by Impact Theory. Specifically, Impact Theory instituted repurchase programs in December 2021 and August 2022 whereby it offered to buy back Founder’s Keys and repurchased 2,936 Founder’s Keys, returning approximately $7.7 million worth of Ethereum to investors. This outcome may suggest that similar remedial actions taken by issuers may mitigate penalties sought by the SEC and encourage reduced settlement payments.

    Impact Theory has undertaken to, among other things, destroy all Founder’s Keys in its possession or control, publish notice of the SEC’s order on its website and social media channels, revise the smart contract underlying the Founder’s Keys to eliminate any royalty it might otherwise receive and assist the SEC staff in administering a plan to distribute monetary relief to affected investors.

    WHAT’S NEXT?

    This first-of-its-kind enforcement action is notable in that the SEC has asserted that certain NFTs are investment contracts. Because this action was ultimately settled by the SEC and Impact Theory, the question remains as to whether a court of law would agree with the SEC’s stance on the offer and sale of NFTs by issuers in similar circumstances. On February 22, 2023, a federal judge in the US District Court for the Southern District of New York issued a first-of-its-kind order allowing a securities class action lawsuit to proceed against the issuer of NFTs on the grounds that the NFTs are securities under federal securities laws. (See Friel v. Dapper Labs, Inc., No. 21 CIV. 5837 (VM), 2023 WL 2162747 (S.D.N.Y. Feb. 22, 2023).)

    SEC Commissioners Hester M. Peirce and Mark T. Uyeda dissented in part based on the SEC’s application of the Howey test analysis and stated that the matter raises larger questions that the SEC should grapple with before bringing additional NFT cases. Specifically, Commissioners Peirce and Uyeda believe the company and purchaser statements cited by the order are not the kinds of promises that form an investment contract, stating, “[W]e share our colleagues’ worry about the type of hype that entices people to spend almost $30 million for NFTs seemingly without having a clear idea about how they will use, enjoy, or profit from them. This legitimate concern, however, is not a sufficient basis to pull the matter into our jurisdiction. The handful of company and purchaser statements cited by the order are not the kinds of promises that form an investment contract.” Commissioners Peirce and Uyeda also questioned whether the facts warranted an enforcement action even if the NFT sales fit within Howey given that the company already made recission offers in the form of repurchase programs. As the dissent noted, the SEC “do[es] not routinely bring enforcement actions against people that sell watches, paintings, or collectibles along with vague promises to build the brand and thus increase the resale value of those tangible items.”

    We regularly advise clients on all types of NFTs, and how they should be treated under US law based on their characteristics, sales and distributions. Our FinTech & Blockchain team can help you navigate the ever-evolving legal landscape affecting your business, ensuring you remain up-to-date and compliant.

    Authors

    Daniel L. Woodard

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • SEC Adopts Substantive Requirements for Advisers to Private Funds

    SEC Adopts Substantive Requirements for Advisers to Private Funds

    ARTICLE / CLIENT ALERT

    SEC Adopts Substantive Requirements for Advisers to Private Funds

    September 1, 2023

    Read time: 14 min

    Key takeaways
    Overview

    On August 23, 2023, the US Securities & Exchange Commission (SEC) adopted new and amended rules (the New Rules) under the Investment Advisers Act of 1940 (Advisers Act) that focus on the SEC’s desire to address what it views to be “risks and harms that are common in an adviser’s relationship with private funds and their investors.” Throughout this article, we will summarize the New Rules, explore their effect on investment advisers to private funds and highlight some of the SEC’s stated views in the adopting release.

    Our discussion of the New Rules has been separated into five parts:

    1. The Restricted Activities prohibit some practices unless certain consent or disclosure obligations are met (walking back many outright prohibitions sought in the rule proposal).
    2. Preferential Treatment restrictions and disclosure obligations, which are generally designed to address side letter arrangements favoring certain private fund investors.
    3. The obligations of advisers to send Quarterly Statements to investors.
    4. Requirements for advisers when undertaking Adviser-Led Secondaries.
    5. The Mandatory Audits provision for private funds and the Written Annual Review requirement to document annual compliance reviews under Rule 206(4)-7.

    The New Rules also add books and records requirements to document compliance.

    In depth

    APPLICABILITY TO REGISTERED INVESTMENT ADVISERS AND OTHER ADVISERS

    The New Rules will apply to all investment advisers registered or required to be registered with the SEC under the Advisers Act, however, the New Rules covering Restricted Activities and Preferential Treatment will apply to any investment adviser, including exempt reporting, state-exempt and registered advisers (e.g., venture capital advisers, small private fund managers and certain US domiciled private funds of non-US-based investment advisers). Persons excluded from the definition of investment adviser will not be affected, such as advisers who meet the “family office” or “bank” exclusions. “Securitized asset funds,” any private fund whose primary purpose is to issue asset-backed securities and whose investors are primarily debt holders are excluded from the New Rules except for the Written Annual Review requirement.

    COMPLIANCE DATES

    • Mandatory Audits and Quarterly Statements – 18 months
    • Restricted Activities, Preferential Treatment and Adviser-Led Secondaries
      • 12 months for advisers with $1.5 billion or more in private funds assets under management
      • 18 months for all other advisers
    • Written Annual Review – 60 days[1]

    RESTRICTED ACTIVITIES

    Investigation Fees and Expenses

    Investment advisers are not permitted to allocate fees and expenses to private funds in connection with any investigation by a regulatory or governmental authority unless the adviser has consulted with all investors of a private fund and has obtained the prior written consent from at least a majority in interest of such private fund’s investors. Consent must be specifically granted by a majority in interest of non-investment adviser-related investors. Consent granted by an investor advisory committee will be insufficient under the rule.

    However, should any Advisers Act sanctions be implemented against the adviser as a result of an investigation, the adviser is prohibited from charging such investigation fees and expenses. Advisers in these circumstances would need to reimburse the private fund for any such fees or expenses for which they previously obtained consent.

    Grandfathering. For any private funds commencing operation prior to the applicable compliance date, the required consent is not required for charging investigation fees and expenses to the private fund so long as the private fund contractual agreements were in place prior to the compliance date and would require the parties to amend the agreement in order to comply. This grandfathering provision does not apply to investigations resulting in Advisers Act sanctions.

    Compliance, Regulatory and Examination Fees and Expenses

    The New Rules prohibit all investment advisers to private funds from charging certain fees or expenses related to the compliance, regulatory and examinations fees and expenses (including the cost of hiring a compliance consultant and legal fees) of the adviser unless the adviser provides written notice to all private fund investors of any such fees and expenses, including the dollar amount, within 45 days from the end of the fiscal quarter in which the charge occurs. We would typically expect this to be disclosed along with the required Quarterly Statements for registered investment advisers, however, there is a disconnect between the year-end statement time and the requirements for fund of funds Quarterly Statements, which would increase the disclosure burdens.

    Investment Adviser Tax Clawback Reductions

    Under the New Rules, an adviser is restricted from reducing the amount of an adviser-carried interest clawback requirement for a private fund by actual, potential or hypothetical taxes applicable to the adviser, its affiliates or their respective owners or interest holders unless the adviser provides written notice to the investors of the private fund within 45 days from the end of the fiscal quarter in which the adviser clawback occurs, setting forth the aggregate pre-tax and post-tax dollar amounts of its clawback. Most registered investment advisers will generally be able to include these amounts along with the required Quarterly Statements, except in the case of the timing mismatch for the year-end statement and requirements for fund of funds.

    Non-Pro Rata Fee and Expense Allocations

    The New Rules also prohibit an adviser from directly or indirectly charging or allocating fees or expenses related to a portfolio investment on a non-pro rata basis among all participating private funds and other clients advised by the adviser unless (i) the non-pro rata charge or allocation is fair and equitable under the circumstances and (ii) prior to charging or allocating such fees or expenses to a private fund, the adviser provides written notice to each investor of the non-pro rata charge or allocation along with a description of how the allocation approach is fair and equitable under the circumstances. The SEC did not explain what a fair and equitable but non-pro rata distribution might be, leaving it to a facts and circumstances analysis that should be documented by the adviser.

    Borrowing

    Advisers are prohibited under the New Rules from directly or indirectly borrowing money, securities or other fund assets or receiving any loan or extension of credit from an advised private fund unless the adviser (i) provides prior written notice to each fund investor (including a description of the material terms of the proposed borrowing, loan or extension of credit) and (ii) obtains written consent from at least a majority in interest of the private fund’s non-adviser-related investors. Investor advisory committees are not able to provide this consent.

    Grandfathering. For any private funds commencing operation prior to the applicable compliance date, the required disclosure and consent are not required so long as the private fund contractual agreements (and the contractual arrangements governing the borrowing), were in place prior to the compliance date and would require the parties to amend the agreement in order to comply.

    Proposed Rules Not Adopted

    The SEC declined to adopt the rule proposal that would have prohibited advisers from seeking indemnification or otherwise limiting the adviser’s liability for its breach of fiduciary duty, willful misfeasance, bad faith, negligence or recklessness in providing services to the private fund. The SEC explained that it believed such a provision was not necessary because of the federal fiduciary duties, which apply to investment advisers. The adopting release discussed the SEC’s long-standing position that advisers cannot waive their federal fiduciary duties and that contract provisions, which “generically” waived such duties, could be a breach. The release raises some questions about how the SEC may view private fund contractual agreements in light of the change from the proposed rule.

    The proposed rule also prohibited charging private funds for unearned compensation, but it was not included in the New Rules. The SEC based this decision on comment letters suggesting that such practices had largely been eliminated and its view that charging fees for unperformed services was a breach of fiduciary duty. The discussion in the release raises questions about how the SEC will apply fiduciary duties in these cases outside of existing enforcement cases.

    PREFERENTIAL TREATMENT

    Favorable Redemption Rights

    The SEC’s new Rule 211(h)(2)-3 prohibits any investment adviser from providing favorable redemption rights to any investor that the adviser reasonably expects to have a material, negative effect on other investors in that private fund except in the case of a redemption right required by applicable law governing the investor or the fund, or if the adviser offers the same redemption rights to all existing and future investors in the private fund. This does not apply to any rights provided to substantially similar pooled investment vehicles managed by the adviser. This restriction is clearly directed at hedge fund (or other funds offering periodic redemptions) practices giving better redemption terms to certain investors to obtain investments from larger and/or strategic investors. The effect on redemption right practices (generally the lack thereof except for legal requirements) for most private equity and other closed-end funds is likely to be minimal.

    Grandfathering. For any private funds commencing operation prior to the applicable compliance date, the restrictions do not apply so long as the private fund contractual agreements were in place prior to the compliance date and would require the parties to amend the agreement in order to comply.

    Favorable Information Rights

    Advisers are also prohibited from providing favorable information rights regarding portfolio holdings or exposures to any investor that the adviser reasonably expects to have a material, negative effect on other investors in that private fund except when the adviser offers the same redemption rights to all existing and future investors in the private fund (including substantially similar pooled investment vehicles). Information disparity is a clear concern for the SEC for private funds permitting periodic redemption because investors need information to make their investment decision on when or how much to redeem from a fund.

    With the new Quarterly Statements requirement, some of the SEC’s risks (and requests from investors) should be mitigated as advisers will be required to disclose commonly requested information on a periodic basis. However, the SEC declined to provide any exceptions for oral communications, citing the material, negative effect standard as sufficient to provide freedom in discussing investments with investors. Advisers will need to be careful in publicly discussing their fund investments, even during fund investor meetings, as all investors may not be in attendance. The SEC further declined to exclude closed-end funds from the rule because some such funds may offer redemption rights in certain extraordinary circumstances and cite security market integrity when certain investors may learn information about a specific portfolio company.

    Grandfathering. For any private funds commencing operation prior to the applicable compliance date, the restrictions do not apply so long as the private fund contractual agreements were in place prior to the compliance date and would require the parties to amend the agreement in order to comply.

    Preferential Treatment Generally

    The New Rules do not allow any type of preferential treatment for any private fund investors unless the adviser (i) provides any prospective investor with written notice describing any preferential treatment related to any material economic terms that the adviser provides to other investors in a private fund (or substantially similar pool) prior to the prospective investor’s investment in the private fund and (ii) provide all investors with written notice of all preferential treatment the adviser has provided to other investors in the fund. For an “illiquid fund” (investors cannot redeem upon request and opportunities to redeem prior to termination are limited), notice must be provided as soon as reasonably practicable following the end of the fund’s fundraising period and on an annual basis thereafter if any new preferential terms have been provided to investors since the prior notice. For a “liquid fund,” notice must be provided as soon as reasonably practicable following the investor’s investment in such private fund and annually thereafter if new preferential treatment is provided.

    The SEC, however, does not define “preferential treatment,” provide any materiality qualifier nor address whether preferential treatment, in this case, was limited to preferential treatment in written agreements with investors (portions of the adopting release refer to “granting” preferential treatment yet the rule used the term “provide” and the release states that preferential treatment can be “provided through various means, including side letters”). When discussing oral statements in the restriction on favorable information rights, the SEC declined exceptions because it believes the material, negative effect standard alleviated concerns that investor communication would be stifled. This provision includes disclosure of “all” direct or indirect preferential treatment, which could include discussions with some investors and not others or any number of activities that not all investors may participate in (such as activities at investor meetings or business meals and entertainment).

    QUARTERLY STATEMENTS

    The SEC’s new Rule 211(h)(1)-2 requires that any SEC-registered investment adviser (including those that are required to be registered) providing investment advice to a private fund must prepare and distribute a quarterly statement to the private fund investors. The statement must include specified information regarding fees and expenses paid or allocated to the private fund or portfolio companies, along with fund and portfolio company performance, and should be presented in a table format with specific line items for certain types of expenses.

    Additionally, quarterly statements prepared for illiquid funds will have to show Gross and Net IRR and MOIC at the fund level as well as Gross IRR and MOIC (each as defined specifically in the New Rules) for each realized and unrealized portfolio investment. Liquid funds are required to provide net total and average returns for the fund over specified periods. Additionally, all statements, regardless of private fund type, must include prominent disclosures with respect to the values of and applicable calculation methodology on how expenses, payments, allocations, rebates, waivers and offsets are calculated. The rule also contains requirements for consolidating the reporting for similar funds.

    Quarterly statements must be provided to investors in private funds (other than funds of funds) no later than 45 days from the end of each of the first three quarters of the fiscal year and within 90 days from the end of each fiscal year. For funds of funds, quarterly statements must be provided no later than 75 days from the end of each of the first three quarters of the fiscal year and within 120 days from the end of each fiscal year.

    ADVISER-LED SECONDARIES

    When an SEC-registered investment adviser offers existing fund investors the choice between selling some or all of their interests in a private fund or converting or exchanging some or all of their interests in the private fund for interests in another vehicle advised by the adviser or any affiliate thereof, the adviser will be required to provide all investors with either a fairness opinion or a valuation opinion from an independent opinion provider prior to their decision. Advisers will also be required to provide a summary to investors identifying any business relationships with the opinion provider in the past two years. We note that the rule excludes tender offers from the scope of adviser-led secondary transactions.

    MANDATORY AUDITS AND WRITTEN ANNUAL REVIEW

    New Rule 206(4)-10 requires all SEC-registered investment advisers to cause the private funds they advise (other than securitized asset funds) to undergo independent audits and distribute the audited financial statements in accordance with the audit exception provision under the Advisers Act custody rule (Rule 206(4)-2). The rule essentially removes the audit requirement from the constraints of the custody rule by including a provision that if an investment adviser provides investment advice to a private fund and does not control and is neither controlled by nor under common control with the private fund, the adviser must take all reasonable steps to cause the private fund to undergo an audit and affect the distribution of such audited financial statements. The New Rules are likely to require audits of private funds in scenarios where the adviser does not have custody of the private fund assets, including the use of unregistered investment advisers (such as non-US managers or bank trustees) as general partners, managing members or trustees. The SEC declined to give specific examples of reasonable steps.

    Finally, the SEC amended Rule 206(4)-7 to require that SEC-registered investment advisers document in writing the annual review historically required by the rule.

    Associate Rafael Calatrava also contributed to this article.

    Authors
    More insights

  • California Reveals Draft Regulations Requiring Onerous Cybersecurity Audits and Privacy Risk Assessments

    California Reveals Draft Regulations Requiring Onerous Cybersecurity Audits and Privacy Risk Assessments

    ARTICLE / CLIENT ALERT

    California Reveals Draft Regulations Requiring Onerous Cybersecurity Audits and Privacy Risk Assessments

    September 1, 2023

    Read time: 8 min

    Key takeaways
    Overview

    On August 28, 2023, the California Privacy Protection Agency (CPPA) released discussion drafts of regulations on cybersecurity audits and privacy risk assessments in advance of the CPPA’s meeting on September 8, 2023.

    These drafts propose extensive, onerous requirements that would exceed other state privacy laws, including the following:

    • Implementing dozens of detailed cybersecurity requirements
    • Conducting a robust audit against those requirements and other risks directly supervised by a company’s board (or senior executive)
    • Submitting an annual certification of completion to the CPPA (signed by a board member or senior executive)
    • Submitting annual privacy risk assessments to the CPPA covering a broader range of “high risk processing” activities and more detailed content requirements than other states

    Companies subject to the California Consumer Privacy Act (CCPA) should pay heed to these proposed regulations, as many of them likely will require months—if not more—of operational lead time to implement.

    In depth

    CYBERSECURITY AUDIT REGULATIONS

    Scope. Every business whose processing of consumers’ personal information presents “significant risk” to consumers’ security must perform an annual cybersecurity audit. The draft regulations propose several potential “significant risk” triggers based on gross revenues, the volume of personal information processed, total number of employees or the percentage of revenue derived from selling or sharing personal information.

    Prescriptive List of Audit Topics. The draft regulations contain a long list of items to be included in the cybersecurity audit, such as

    • How the business’s cybersecurity program considers and protects against specified negative impacts to consumers’ security
    • Risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect consumers
    • Written documentation of the business’s cybersecurity program, safeguards used to protect personal information, the effectiveness of these cybersecurity program components, identification of gaps or weaknesses, and the business’s plans to address any gaps and weaknesses
    • If the business was required to provide a data breach notification in any jurisdiction, even in another country, a description of the notification, as well as the date and details of the activity that gave rise to the notification and any related remediation measures taken by the business

    In total, the draft regulations include nearly six pages of cybersecurity program elements that companies must either implement or document how alternative safeguards achieve the same level of security. The safeguards include: data segregation, data and systems mapping, multi-factor authentication, internal and external vulnerability scans and penetration testing, vendor oversight, incident response planning documentation and preparation, zero trust architecture, record retention schedules and secure development of coding. In short, the draft regulations could become the most prescriptive set of cybersecurity requirements implemented by any state.

    Performed by an Independent Auditor. The individual conducting the cybersecurity audit must be a qualified, objective, independent professional. If an internal resource is used, the auditor (1) cannot have any role developing or maintaining the cybersecurity program or perform activities subject to the audit and (2) must report directly to the board or, if there is no board, the highest-ranking officer in the business who does not have direct responsibility for the business’s cybersecurity program.

    Board Signature Required. A business required to complete a cybersecurity audit must annually submit to the CPPA either (1) a written certification that the business complied with the cybersecurity audit regulations during the 12 months that the audit covers or (2) a written acknowledgment that the business did not fully comply. The submissions must be signed by a member of the board or governing body, or if none exists, the business’s highest-ranking executive with authority to bind the business.

    PRIVACY RISK ASSESSMENT

    Scope. Businesses must conduct and document a privacy risk assessment prior to any processing of consumers’ personal information that “presents significant risk to consumers’ privacy.” The draft regulations require such assessments for a much broader set of processing activities than other states with consumer privacy laws, including

    • Selling or sharing personal information
    • Processing sensitive personal information, except for the sensitive personal information of employees or independent contractors for the purposes of employment authorization, payroll, health plan and benefits management, or wage reporting
    • Using Automated Decision-making Technology in furtherance of a decision that results in the provision or denial of financial or lending services, housing, insurance, education enrollment or opportunity, criminal justice, employment or contracting opportunities or compensation, healthcare services, or access to essential goods, services or opportunities
    • Processing the personal information of consumers who the business knows are under 16
    • Processing the personal information of consumers who are employees, independent contractors, job applicants or students using monitoring technology
    • Processing the personal information of consumers in publicly accessible places using technology to monitor their behavior, location, movements or actions
    • Processing the personal information of consumers to train artificial intelligence or Automated Decision-making Technology

    Content of Risk Assessments. In a Colorado-like fashion, the draft regulations include a long list of processing explanations, as well as risks and benefits, to be included in the privacy risk assessment, which go beyond the requirements of other state privacy risk assessments. In addition to a summary of the processing, under the draft regulations, assessments would have to include an operational plan (e.g., how the business will collect, minimize and secure data) and an assessment of 10 potential harms to data subjects, ranging from psychological to constitutional.

    Automated Decision-Making Technology and Artificial Intelligence. In addition to the basic assessment requirements, the draft regulations include additional requirements for (1) businesses using Automated Decision-making Technology for certain purposes and (2) businesses that process personal information to train artificial intelligence or Automated Decision-making Technology. At first blush, many companies could not be faulted for thinking that these requirements would not apply. However, the proposed definitions of “artificial intelligence” and “Automated Decision-making” are so broad that they would sweep in almost any use of a computer—or even an Excel formula.

    • “Artificial intelligence” is defined as an engineered or machine-based system that is designed to operate with varying levels of autonomy and that can, for explicit or implicit objectives, generate outputs such as predictions, recommendations or decisions that influence physical or virtual environments. Artificial intelligence includes generative models, such as large language models, that can learn from inputs and create new outputs, such as text, images, audio or video, as well as facial or speech recognition or detection technology.
    • “Automated Decision-making Technology” is broadly defined as any system, software or process—including one derived from machine learning, statistics other data-processing techniques, or artificial intelligence—that processes personal information and uses computation as whole or part of a system to make or execute a decision or facilitate human decision-making. Notably, this expansive definition conceivably could encompass any use of a computer to “facilitate” decision-making.

    We anticipate that these definitions will be the subject of much public comment if the CPPA formally proposes these rules.

    Submission of Risk Assessment. Businesses must annually submit to the CPPA (1) the business’s privacy risk assessments in an abridged form and (2) a certification by a designated executive that the business has complied with the requirements of the risk assessment regulations. Businesses must also make privacy risk assessments available to the CPPA or the California Attorney General upon request. Unlike other state consumer privacy laws, however, the draft regulations do not preserve the privilege or work product protections that might otherwise attach to a company’s risk assessments.

    WHAT’S NEXT?

    The draft regulations will be discussed by the CPPA board at the September 8 meeting. We anticipate that additional changes will be made by the CPPA before the proposed regulations are submitted in a formal rulemaking process. While companies may still have a chance to influence some of the more onerous provisions of these regulations, if the last rulemaking process was any guide, the changes may be minimal. Therefore, companies should take the time to benchmark their operations against the draft regulations to identify any significant gaps and create a work plan for how to address those gaps.

    If you have questions or need assistance with CCPA compliance or other state privacy laws, please contact any of the authors or your regular McDermott lawyer.

    Check out our additional coverage on new state consumer privacy laws: 

    State Regulators Step Up Enforcement of New Privacy Laws

    Ruling Delays Enforcement of Latest CCPA Regulations

    Oregon Joins the Consumer Privacy Trend

    Texas Consumer Privacy Law Nears Governor’s Signature

    Florida Adds a New Twist to Consumer Privacy Patchwork

    Tennessee Joins the Fray as Legislature Passes Consumer Privacy Law

    Consumer Privacy Law Comes to Big Sky Country as Montana Passes New Law

    Indiana Passes Consumer Privacy Bill

    Iowa’s New Privacy Law: The Basics

    Colorado Finalizes Sweeping New Privacy Rules; Iowa Joins the Fray

    Preparing for New Consumer Privacy laws in Colorado, Connecticut and Utah

    Authors

    Elliot R. Golding

    Partner

    Washington, DC

    David P. Saunders

    Partner

    Chicago

    More insights

  • Mobility@McDermott: Monthly Update (08/2023)

    Mobility@McDermott: Monthly Update (08/2023)

    ARTICLE / CLIENT ALERT

    Mobility@McDermott: Monthly Update (08/2023)

    September 01, 2023

    Read time: 9 min

    Key takeaways
    Overview

    1. Federal Court of Justice rules on bank’s right of retention after withdrawal from loan and purchase agreements if consumer sells vehicle
    Germany’s highest civil court, the Federal Court of Justice (Bundesgerichtshof, “BGH”), recently issued two rulings regarding the scope of a bank’s right of retention after a consumer withdraws from a loan agreement that is linked to a purchase agreement. In both cases, the consumer had purchased a car and financed the purchase price with a bank.

    As with all consumer loan agreements (subject to limited exceptions), the consumers had a statutory withdrawal right for 14 days regarding the loan agreement (sec. 495 German Civil Code, Bürgerliches Gesetzbuch (“BGB”)). If the contract from which the consumer with-draws is closely linked to another contract and both contracts form an economic unit – in the case of the vehicle, the loan agreement and the purchase agreement, because the purchase price is financed – the effect of the withdrawal also extends to the purchase agreement as a linked contract (sec. 358 et seq. BGB).

    In both cases, the BGH ruled that the consumers were able to withdraw well after the usual 14 day period had expired because the bank’s mandatory information on the interest rate owed under the loan agreement was incomplete.

    After withdrawal from a contract, the parties must return to each other what they have received in the performance of the contract. In the case of consumer goods, the seller may refuse to make such repayment until he has received the returned goods or the consumer has provided proof that the goods have been dispatched (sec. 357 para. 4 BGB).

    In both cases decided by the BGH, the consumers had sold the financed vehicles to third parties at some point and repaid the loans in full while continuing to pursue the case in court. They then asked the banks to return all payments made under the loan agreements. The bank refused, arguing that it now had a permanent right of retention over the repayments because, having sold the vehicles, the consumers were permanently unable to make the vehicles available to the bank.

    The BGH sided with the banks, thereby resolving a longstanding debate in the legal community.

    Further details (available only in German):
    Click here and here.

    Relevant for: Mobility providers, finance providers.

    2. Court ruling on the scope of the obligation to pay interest when a consumer with-draws from a loan agreement for the purchase of a vehicle
    The Higher Regional Court of Cologne (Oberlandesgericht Köln) ruled on how long a consumer must pay interest on a loan taken out to finance the purchase of a vehicle if the consumer withdraws from the contracts.

    In this case, a consumer had purchased a vehicle and financed the purchase with a bank. As with all consumer loan agreements (subject to limited exceptions), the consumer had a statutory withdrawal right for 14 days regarding the loan agreement (sec. 495 German Civil Code, Bürgerliches Gesetzbuch (“BGB”)). If the contract from which the consumer withdraws is closely linked to another contract and both contracts form an economic unit – in the case of the vehicle, the loan agreement and the purchase agreement, because the purchase price is financed – the effect of the withdrawal also extends to the purchase agreement as a linked contract (sec. 358 et seq. BGB).

    According to German law, after withdrawing from the contracts, the consumer is still obliged to pay the agreed interest for a time period beginning with the disbursement of the loan amount (sec. 357b para. 3 BGB). However, there are differing views as to when this obligation ends. In its decision, the Higher Regional Court of Cologne ruled that the consumer must pay interest until he returns the vehicle to the lender (who, for the purposes of reversing the contractual relationships, assumes the role of the seller under the purchase agreement). The court argues that this is justified because the consumer can make use of the purchased good until it is returned. Other courts had ruled in the past that consumers were only obliged to pay interest until they declared their withdrawal from the contract.

    Until Germany’s highest civil court, the Court of Justice (Bundesgerichtshof), rules on the matter, it is likely to remain a subject of debate.

    Further details here (available only in German and behind paywall)

    Relevant for: Mobility providers, finance providers.

    3. The European Commission accepts requests to review transactions that meet no European merger control threshold
    On Friday 18 August 2023, the European Commission, under Article 22 of the European Merger Control Regulation (“EUMR”), accepted the request of various EU Member States to review Qualcomm’s planned acquisition of Autotalks, an Israeli semiconductor manufacturer specialized in vehicles-2-everything.

    Article 22 EUMR is not new. However, the use and interpretation of the Commission and Member State’s remit is. On 26 March 2021, the Commission published new guidance that allowed it to review any transaction that (i) affects trade, and (ii) threatens to significantly affect competition within the territory of a Member State. The Member State may refer such transaction to the Commission for review, even if the jurisdictional thresholds are not met.

    While the guidance focused on digital and pharma sectors, which are innovation driven, the Commission by accepting the request highlights that the application of Article 22 is not sector specific and the competition authorities of the Member States can use this power to catch any and all transactions that potentially raise concerns. In fact, on the same day, the Commission accepted another request to review the acquisition of Nasdaq Power by EEX (both active in on exchange trading of power contracts).

    While the European Court of Justice is set to rule on the guidance and (new) interpretation of Article 22, companies and their counsel should consider closely potential competitive effects of their transactions.

    Further details here (available in English)

    Relevant for: All companies.

    4. European Digital Services Act to be implemented in Germany
    The Federal Ministry for Digital Affairs and Transport has published a draft law for the implementation of the European Digital Services Act (Regulation (EU) 2022/2065) (the latter, the “DSA”). As a reminder: The DSA introduces a comprehensive framework for online platforms. While at its surface it mostly aims at large social platforms, it will apply to certain online marketplaces as well, especially those platforms that connect consumers and businesses to enter into distance contracts (Fernabsatzverträge). Regarding the latter, the regulation will require the platform provider to, inter alia, include certain provisions in their terms and conditions and to identify the persons that intend to offer products on the platform (like a “know-your-customer light” obligation). Breaches of the regulation might result in fines and will give platform users a claim for damages.

    The DSA provides for a ramp-up period: It has applied to certain platforms since 16 November 2022, whereas it will start to apply for a bulk of other platforms from 17 February 2024 on. Companies therefore only have a couple of months left to check whether they are in scope of the regulation (there are a couple of helpful exemptions!) and make the required amendments.

    While the DSA as an EU regulation applies directly in Germany, it still requires a local law to set out, inter alia, the competencies of the local authorities. This is what the German draft implementation law is about: It proposes the German Bundesnetzagentur as competent authority. In addition, it aligns several other laws already in effect in Germany with the DSA.

    Further details on the implementation law here (available only in German)

    The DSA can be found here

    Relevant for: Vehicle platform provider (e.g. used car sales platform providers and, depending on the contractual structure, vehicle subscription providers).

    5. German government releases guidance on cooperation in supply chain
    The German Federal Office for Economic Affairs and Export Control (Bundesamt für Wirtschaft und Ausfuhrkontrolle, “BAFA”) and the Helpdesk on Business & Human Rights, a service offered by the German federal government, have published guidance on supply chain collaboration.
    The document focuses on the implications of Germany’s Act on Corporate Due Diligence Obligations in Supply Chains and is intended to inform companies about what they should be asking of their suppliers when intending to comply with the legal framework. It provides helpful practical guidance on a subject with which many businesses are still unfamiliar.

    Relevant for: OEMs, suppliers.

    6. Draft of revised Road Traffic Act (Straßenverkehrsgesetz) released by German government
    On 18 August 2023, the German government initiated an amendment to the Road Traffic Act (Straßenverkehrsgesetz, “StVG”) implementing a voluntary commitment made in the coalition agreement.

    Up to now, the fluidity and safety of traffic were the decisive references of road traffic law, with the result that car traffic was given priority in cities. In the future, climate and environ-mental protection, health and urban development will also be taken into account. Therefore, the new regulations of the StVG intend to give the states and the responsible municipal authorities more leeway for decision-making to be able to meet specific local requirements more quickly and flexibly.

    If passed, the amendment of the Road Traffic Act will pave the way for new regulations in the Road Traffic Law, especially the Road Traffic Ordinance (Straßenverkehrsordnung), which will then standardize new authorizations for municipal authorities (such as, e.g., orders for special lanes for certain climate-friendly types of mobility or 30 km/h zones).

    Further details here (available only in German)

    Relevant for: Mobility Providers.

    7. Updated vehicle registration ordinance to be become effective in September 2023
    The new German vehicle registration ordinance will come into effect on 1 September 2023. Under the new rules, both consumers and businesses will be able to register vehicles in a digital process without having to visit a government office. Previously, there was no option for car dealers to register vehicles digitally.

    Under the new rules, both consumers and businesses will also have the right to immediately use the vehicle on the road for a period of up to ten days after digitally registering a vehicle while the paperwork and the required stickers for the license plates are being sent out by the authorities. This makes the registration process much more flexible. During the pandemic, appointments for in-person vehicle registration were scarce especially in bigger German cities, resulting in week-long delays before vehicles could be put on the road.

    Further details here and here (available only in German)

    Relevant for: Mobility Providers, vehicle manufacturers.

    In depth
    Authors

    Dr. Antje Weiss

    Counsel

    Düsseldorf

    Max Küttner

    Associate

    Düsseldorf

    More insights

  • No Surprises Act Update: The TMA III Decision

    No Surprises Act Update: The TMA III Decision

    ARTICLE / REPORT

    No Surprises Act Update: The TMA III Decision

    August 31, 2023

    Read time: 2 min

    Overview

    The Texas Medical Association and additional plaintiffs have brought four Administrative Procedure Act (APA) challenges to the rules and guidance implementing the No Surprises Act (NSA) (termed TMA I, II, III and IV). The plaintiffs filed all four challenges in the US District Court for the Eastern District of Texas, Tyler Division. District Judge Jeremy Kernodle heard all four actions and released his opinion in TMA III on August 24, 2023. The US Department of Justice (DOJ) has not yet stated whether it will appeal or seek a stay of TMA III. If TMA III stands, it will have a significant impact on processing and payment of out-of-network claims, out-of-network cost sharing paid by patients and operation of the federal independent dispute resolution (IDR) process. This report summarizes the TMA III court decision and assesses the potential next steps available to the US Departments of Health and Human Services, Labor and Treasury (the Departments).

    In depth
    Tabs
    More insights
    Endnotes

  • Healthcare Regulatory Check-up Newsletter | July 2023 Recap

    Healthcare Regulatory Check-up Newsletter | July 2023 Recap

    ARTICLE / REPORT

    Healthcare Regulatory Check-up Newsletter | July 2023 Recap

    August 31, 2023

    Read time: 2 min

    Overview

    This issue of McDermott’s Healthcare Regulatory Check-Up highlights significant regulatory activity for July 2023. We discuss several criminal and civil enforcement actions that involve violations of the False Claims Act (FCA) and the Anti-Kickback Statute (AKS). We also review several major reimbursement regulatory updates and a recent advisory opinion issued by the Office of the Inspector General (OIG).

    In depth
    Tabs

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Caroline Reignley

    Partner

    Washington, DC

    Monica Wallace

    Partner

    Chicago

    More insights
    Endnotes

  • Update Future Financing Act – Focus on Financial Supervisory Law

    Update Future Financing Act – Focus on Financial Supervisory Law

    ARTICLE / CLIENT ALERT

    Update Future Financing Act – Focus on Financial Supervisory Law

    August 31, 2023

    Read time: 10 min

    Key takeaways
    Overview

    With the ambitious goal of strengthening the performance of the German capital market and increasing the attractiveness of Germany as a financial location in the European financial center, the draft bill for a law on the financing of future-proof investments (“Draft Bill”) was published by the Federal Ministry of Finance and the Federal Ministry of Justice on April 12, 2023. The Draft Bill contained a large number of proposed amendments under company, financial market and tax law. This was followed on August 17, 2023 by the publication by the German government of a draft bill for a law on the financing of future-proof investments (Future Financing Act – “ZuFinG-E” and “Government Draft“). This draft translates the government’s intention to promote future-oriented investments into more concrete legal form and will go through the legislative process of the German Parliament.

    In the following overview, we outline the main changes resulting from this for the financial supervisory law.

    In depth

    MAIN CONTENTS
    I. Electronic and English-language communication with public authorities
    For international market participants, the German financial market should be more easily accessible in the future, which is why the German Financial Supervisory Authority (“BaFin”) should be enabled to communicate with market participants in English as the international working language, over and above the existing legal leeway:

    • Applications can be submitted in English in the future by supplementing the Financial Services Supervision Act (“FinDAG”). Administrative specifications and forms relevant for international market participants are to be made available in English more quickly and more comprehensively (Section 4j FinDAG-E).
    • In addition, it should be possible in the future, for example through an amendment to the Ownership Control Ordinance (Inhaberkontrollverordnung – “InhKontrollV”), for interested acquirers and owners of significant shareholdings to communicate with BaFin in ownership control proceedings in English.

    In addition to English-language communication, written form requirements in supervisory law are to be replaced by digital communication options. For example, the Payment Services Supervision Act (Gesetz über die Beaufsichtigung von Zahlungsdiensten – “ZAG“) is to be amended to create the basis for companies subject to licensing and registration requirements to communicate with BaFin electronically in the context of licensing and registration (Section 4a ZAG-E). In the past, communication between BaFin and the institutions could already take place in part via a portal set up by BaFin, without there being any statutory regulation for ZAG institutions in this regard.

    Furthermore, electronic and English-language communication with authorities is to be comprehensively supplemented by parallel regulations in further supervisory laws. In practice, the option of English communication and the waiver of the numerous written form requirements under supervisory law promise considerable advantages in the context of the usually already extensive requirements for communication with BaFin. The proposed amendments from the Draft Bill have been incorporated into the Government Draft without any significant adjustments.

    II. Introduction of the electronic share
    Already laid down in the coalition agreement and legally elaborated in the Government Draft, the scope of the Electronic Securities Act (Gesetz über elektronische Wertpapiere – “eWpG“) is to be extended to electronic shares. To date, only bearer bonds and investment fund share certificates could be issued electronically under the eWpG. The proposed amendments to the eWpG and the German Stock Corporation Act (Aktiengesetz – “AktG“) are intended to make this possible for electronic shares as well in the future. With regard to the electronic central register share, Germany is thus catching up with other countries where electronic share custody has long been standard. The introduction represents a novelty in German stock corporation law and will make a decisive contribution to opening up the financial market for companies and investors.

    Further information on the proposed introduction of the electronic share can be found in our Client Briefing Future Financing Law – Focus on Stock Corporation and Capital Market Law.

    III. Adjustment of the liability rules for Crowd Funding Projects
    Easing of liability for crowdfunding projects: In the future, crowdfunding for project promoters and crowdfunding service providers is expected to become more attractive due to the limitation of liability rules. The existing liability rules for Key Investment Information Sheets (“KIIS“) in the case of swarm financing projects are to be aligned with the liability rules for investments such as securities and asset investments. At the same time, this also enables the improvement of the enforcement of compensation claims for the investor:

    • A revision of the liability rules set out in Sections 32c, 32d and 32e (1) of the German Securities Trading Act (Wertpapierhandelsgesetz – “WpHG“) is initially intended to eliminate the direct liability of members of the management and supervisory bodies of project sponsors and providers of crowdfunding services.
    • Whereas in the Draft Bill the fault of the project sponsor or the crowdfunding service provider was still rebuttably presumed, as is customary in German supervisory law, according to the Government Draft liability will only be considered in the future if negligence can be proven.
    • Furthermore, liability due to incorrect or missing information in a KIIS or due to missing declarations to be made shall be limited to the refund of the investment made by the investor.

    The draft thus creates, at least to a large extent, the required uniformity of the supervisory liability standard.

    IV. Introduction of specifications for crypto custody
    In view of current events on the crypto market, this is a very relevant topic for the financial industry: The newly adopted Regulation (EU) 2023/1114 on Markets in Crypto-Assets (“MiCAR“) also includes regulations for the protection of client assets in the event of the insolvency of crypto custodians. The Future Financing Act is intended to keep crypto assets in custody out of the reach of the crypto custodian’s general creditors even before MiCAR takes effect or its transition period ends. The failures of crypto exchanges show how practically relevant and important a corresponding regulation is in order to create security for companies and investors.

    1. Introduction of an asset segregation requirement
    The ZuFinG-E obliges crypto custodians to take precautions to separate their own crypto assets from crypto assets in custody and to no longer dispose of them without explicit consent. To implement the asset segregation requirement, the Draft Bill provides for an amendment to the German Banking Act (Kreditwesengesetz – “KWG“).

    Crypto custodians must keep crypto assets and customers’ private cryptographic keys separate from their own and other customers’ assets. Bundled custody as in the case of the omnibus solution should remain possible, but it must be ensured that the individual shares can be determined and assigned to the respective customer at any time.

    If the crypto custodian violates these obligations, it commits an administrative offense that can be punished with a fine of up to EUR 500,000.00.

    2. Regulation of the allocation of crypto assets held in custody and the right of customers to segregate such assets
    The clear separation provisions are complemented by the strengthening of customer rights in the event of the custodian’s insolvency. The crypto assets in custody, including the private cryptographic keys, must remain inaccessible to the crypto custodian’s general creditors, which is once again clarified by a supplementary provision. This will enable the customers to oppose an access under enforcement law with the third-party action (Section 771 ZPO). In addition, they will then be entitled to a right of segregation (Section 47 InsO) in insolvency proceedings regarding the assets of the crypto custodian. The starting point is the statutory provision in a new Section 46i (1) KWG, according to which a customer’s crypto asset held in custody is deemed to belong to the customer. However, this fiction is to cease to apply if the customer has previously given his consent to the disposal of the assets for the account of the institution or third parties. The exact requirements for consent remain to be seen.

    With regard to the right to segregation, the Government Draft specifies that the customer bears the costs of segregation if he does not consent to the transfer to a crypto custodian determined by the insolvency administrator. However, this is to be waived as an exception if the conditions of this crypto custodian are unreasonable. The conditions shall be deemed unreasonable, for example, if the custody fees charged are disproportionately high or if the customer is offered less security for the crypto assets held in custody.

    V. Introduction of regulations for the DLT Pilot Regime
    In line with the objective of the Draft Bill to make the German financial market more accessible for start-ups, growth companies and small and medium-sized enterprises through digitalization and internationalization, the Government Draft includes accompanying regulations to the so-called DLT pilot regime already in place.

    The DLT pilot scheme, under which a temporary test environment (regulatory sandbox) is made possible for market infrastructures based on distributed ledger technology (“DLT“), has already come into effect. Market participants can gain initial experience in trading tokenized financial instruments. It applies to all market participants that enable decentralized trading as well as decentralized settlement.

    As the DLT pilot regime contains requirements and exemptions for DLT-based market infrastructures, an adjustment of the national regulatory requirements will be necessary:

    • The ZuFinG-E therefore provides, among other things, for the inclusion of new provisions in the KWG and the Securities Institutions Act (Wertpapierinstitutsgesetz – “WpIG“), according to which the activities permitted under the DLT pilot regime do not trigger any additional licensing requirement under the KWG or WpIG.
    • In addition, BaFin is to be the competent authority within the meaning of DLT pilot regime and, in deviation from the previous principle of German-language communication with authorities, is to determine that documents may also be prepared and submitted in English (Sections 53r, 53u (1), 78a, 78c (1) KWG-E).
    • In addition, applications relating to the DLT pilot regime are to be permitted to be transmitted purely electronically (Sections 53u (2), 78c (2) KWG-E). According to the Government Draft, the transmission channel and the data format are to be determined by BaFin.

    VI. New regulations in payment services law
    1. Exception from Terms & Conditions Control for contracts between financial entrepreneurs
    For T&Cs between banks and other financial service providers, an area exemption from T&C control is to be introduced for contracts on transactions requiring a license under the KWG, the WpIG and ZAG (Section 310 (1a) BGB-E). In contrast to the Draft Bill, however, the Government Draft no longer requires that the actors have a permit under these laws and are supervised. Instead, it should suffice to prove that the contracting entrepreneurs are permitted to carry out this type of business in general or the specific business lawfully.

    The purpose of the area exception is to enable contracts under German law to be structured in a legally secure manner in accordance with the internationally applicable standards. Up to now, there has been considerable legal uncertainty as to the extent to which the standard contractual clauses that are customary in practice and are also drafted with regard to regulatory provisions also comply with the requirements of T&C law, if there is no case law on this yet.

    2. BaFin comparison website for payment account fees
    In order to ensure that a comparison website for payment account fees is permanently available to consumers in compliance with European law, a comparison website operated by BaFin is also to be established (Section 16 (1) of the Draft Payment Accounts Act – “ZKG-E”).

    A legal obligation for payment service providers to report data on comparison criteria to BaFin is also to be introduced in order to be able to efficiently and effectively cover the essential part of the German market in payment account comparison (Section 17 (2) ZKG-E).

    VII. Outlook
    The Government Draft will go through the legislative process in the near future, and its conclusion is planned for the fall or winter of this year. While the majority of the regulations are expected to enter into force the day after the Future Financing Act is promulgated in the Federal Law Gazette, this is scheduled for January 1, 2024 for some other regulations. We look forward to continuing to keep you informed of developments in the planned Future Financing Act!

    Authors

    Annabelle Juliette Rau

    Associate

    Cologne

    More insights

  • M&A-Market: “Strategically driven deals are still worthwhile”.

    M&A-Market: “Strategically driven deals are still worthwhile”.

    ARTICLE

    M&A-Market: “Strategically driven deals are still worthwhile”.

    August 30, 2023

    Read time: 2 min

    Key takeaways
    Overview

    In an environment full of uncertainties, the corporate transaction sector is coming under increasing pressure. In view of declining M&A deals in 2022 compared to the previous year and the ongoing crises in 2023, potential buyers and sellers are reacting with caution. In an exclusive interview with the Unternehmeredition, Dr Philipp Grenzebach talks about the current opportunities and challenges.

    In depth
    Authors

    Dr. Philipp Grenzebach

    Partner

    Düsseldorf, Frankfurt

    More insights